Blog – Page 17 – Scilex Holding

Blog

15 Nov

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

15 Nov

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

15 Nov

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

15 Nov

Initial statement of changes in beneficial ownership of securities

December 14, 2022
Posted by Jitendra

15 Nov

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

15 Nov

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

14 Nov

Statement of acquisition of beneficial ownership by individuals – Amendment

November 17, 2022
Posted by Jitendra

Read More

11 Nov

Opening Bell Nov 11, 2022

July 19, 2024
Posted by scilexpharma

Opening Bell Nov 11, 2022

10 Nov

Notification of removal from listing and/or registration

November 17, 2022
Posted by Jitendra

10 Nov

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business Combination

November 10, 2022
Posted by Jitendra

Approximately 80% of the shareholders of Vickers present at the meeting of Vickers shareholders in connection with the business combination voted in favor of the business combination. Scliex’s shares of common stock and...

«‹15 161718 19 ›»